Recently, the United States drugmaker asked the European Medicines Company (EMA) to re-evaluate its Alzheimer’s medication Kisunla.
发布者：BY ELLEN BIRKNER，转转请注明出处：https://robotalks.cn/ema-to-reconsider-rejection-of-eli-lillys-treatment-for-alzheimers/
EMA to reconsider rejection of Eli Lilly’s treatment for Alzheimer’s
赞 (0)
关于作者
AstraZeneca CEO warns against US tariffs on medicines
上一篇
29 4 月, 2025 5:19 下午
Pfizer beats earnings expectations
下一篇
29 4 月, 2025 5:19 下午
相关推荐
-
Universal Robots Changed the Way We Sell Robots
I have had the satisfaction of seeing just how much points have actually can be found in the globe of movement control and robotics over the previous twenty years. Helping a firm t…
-
How the Chief AI Officer at Children’s National approaches clinical and admin automation
Alda Mizaku states the health and wellness system additionally is making use of expert system to improve anticipating analytics initiatives, to name a few usage instances. And she …
-
Next-Gen Gas Sensors Will Redefine Industrial Safety
Positioning the suitable sensing units purposefully throughout a location is a vital precaution– laid out in numerous criteria and laws– that safeguards employees in lo…
-
Rockwell Automation Opens Registration to Automation Fair 2024 and Expands Expo
4 complete days of developments, finding out chances and links get on faucet at the leading yearly commercial automation and electronic makeover occasion.
-
Alta Resource raises extra $4.4m to advance biochemical separation of REEs
Alta Source will certainly make use of the brand-new financing to increase advancement of a system for biochemical splitting up of unusual planet components (REEs) The article Alta…
